marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-18-2024
Cellectar Biosciences Income Statement 2011-2024 | CLRB
Annual Income Statement Cellectar Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
44.5 M | 11.9 M | 3.33 M | 26.2 M | 20.3 M | 5.98 M | 17.4 M | 7.17 M | 4.3 M | 11 M | 22.8 M | 29.2 M | 10 M |
Shares |
12.2 M | 7.06 M | 5.55 M | 13.8 M | 7.68 M | 2.96 M | 1.4 M | 454 K | 78.2 K | 45.9 K | 30 K | 20 K | 10 K |
Historical Prices |
3.64 | 1.69 | 0.6 | 1.9 | 2.68 | 1.95 | 11.7 | 16.3 | 55 | 241 | 700 | 1.44 K | 960 |
Net Income |
-42.8 M | -31.8 M | -24.1 M | -15.1 M | -14.1 M | -13.2 M | -13.6 M | -6.18 M | -5.5 M | -8.11 M | -10.8 M | -8.8 M | -7.44 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-39 M | -28.8 M | -24.1 M | -15.3 M | -14.2 M | -13.3 M | -13.6 M | -9.45 M | -8.76 M | -9.89 M | -12.4 M | -8.75 M | -7.04 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-38.8 M | -28.7 M | -24 M | -15.1 M | -14 M | -11.6 M | -12.1 M | -9.09 M | -8.19 M | -9.3 M | -10.9 M | -8.26 M | -5.71 M |
Operating Expenses |
- | - | - | 15.3 M | 14.2 M | 11.7 M | 13.6 M | 9.45 M | 8.55 M | 9.67 M | 11.3 M | 8.75 M | 6.29 M |
General and Administrative Expenses |
11.7 M | 10.5 M | 6.54 M | 5.15 M | 5.18 M | 4.82 M | 4.14 M | 4.7 M | 3.4 M | 3.7 M | 4.44 M | 3.63 M | 2.69 M |
All numbers in USD currency
Quarterly Income Statement Cellectar Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
39.3 M | 35.8 M | 29.3 M | 20.7 M | 11.3 M | 11.3 M | 11.3 M | 9.39 M | 6.11 M | 6.11 M | 6.11 M | 6.11 M | 5.99 M | 52.8 M | 48.1 M | 45.4 M | 26.3 M | 13.8 M | 9.39 M | 9.39 M | 9.39 M | 6.96 M | 4.77 M | 4.73 M | 3.18 M | 1.73 M | 1.68 M | 1.67 M | 1.35 M | 1.35 M | 12 M | 10.4 M | 5.37 M | 4.33 M | 858 K | 858 K | 756 K | 756 K | 756 K | 756 K | 5.01 M | 2.87 M | 2.87 M | 2.87 M | 2.87 M | 2.87 M | 51.3 M | 46.4 M | 43.3 M | 38.6 M | 36.9 M | 36.9 M | 26.8 M | 25.7 M | 36.9 M |
Net Income |
-14.7 M | -919 K | -21.6 M | - | -17.5 M | -10.2 M | -8.58 M | - | -7.81 M | -7.44 M | -6.14 M | - | -5.82 M | -6.03 M | -6.36 M | - | -3.91 M | -3.61 M | -3.96 M | - | -3.9 M | -3.19 M | -3.62 M | - | -3.01 M | -2.92 M | -3.48 M | - | -3.47 M | -3.12 M | -2.89 M | - | -2.29 M | -2.13 M | 825 K | - | -1.86 M | -2.29 M | -2.3 M | - | 324 K | -2.09 M | -2.94 M | - | -1.32 M | -2.06 M | -3.45 M | - | -2.05 M | -2.23 M | -2.36 M | - | -1.91 M | -2.6 M | -965 K |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-13.3 M | -13.7 M | -12 M | - | -9.41 M | -8.29 M | -8.71 M | - | -7.82 M | -7.44 M | -6.14 M | - | -5.82 M | -6.03 M | -6.36 M | - | -3.91 M | -3.62 M | -3.96 M | - | -3.96 M | -3.2 M | -3.63 M | - | -3.09 M | -2.9 M | -3.45 M | - | -3.48 M | -3.22 M | -2.81 M | - | -2.47 M | -2.33 M | -2 M | - | -2.09 M | -2.29 M | -2.59 M | - | -2.27 M | -2.55 M | -2.82 M | - | -2.91 M | -2.72 M | -2.71 M | - | -2.05 M | -2.21 M | -2.33 M | - | -1.91 M | -2.25 M | -854 K |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -11.9 M | - | - | - | -8.66 M | - | -7.71 M | -7.44 M | -6.1 M | - | -5.71 M | -6.03 M | -6.32 M | - | -3.8 M | -3.55 M | -3.92 M | - | -3.86 M | -3.13 M | -3.6 M | - | -3.04 M | -2.87 M | -3.44 M | - | -3.19 M | -3.03 M | -2.73 M | - | -2.2 M | -2.15 M | -1.91 M | - | -1.82 M | -2.11 M | -2.5 M | - | -2 M | -2.36 M | -2.72 M | - | -2.58 M | -2.5 M | -2.6 M | - | -1.67 M | -1.95 M | -2.19 M | - | -1.47 M | -1.96 M | -709 K |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
7.83 M | 6.36 M | 4.62 M | - | 2.38 M | 2.16 M | 2.05 M | - | 2.44 M | 2.94 M | 2.25 M | - | 1.88 M | 1.4 M | 1.73 M | - | 1.23 M | 1.16 M | 1.34 M | - | 1.26 M | 1.39 M | 1.32 M | - | 1.09 M | 1.18 M | 1.33 M | - | 1.15 M | 1.04 M | 955 K | - | 1.16 M | 1.37 M | 961 K | - | 835 K | 818 K | 943 K | - | 803 K | 960 K | 1.09 M | - | 844 K | 1.07 M | 1.12 M | - | 801 K | 897 K | 998 K | - | 905 K | 797 K | 132 K |
All numbers in USD currency